Strategic Analysis of World Emerging Neurological Therapeutics Markets

 


This research service evaluates the emerging neurlogical therapeutics markets for Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Factors affecting market growth, existing market trends, pipeline trends, challenges, strategic product profiles, revenue analysis, and awards are presented for each therapeutic area.

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

Table of Contents

Strategic Analysis of World Emerging Neurological Therapeutics Markets, Strategic Analysis of World Emerging Neurological Therapeutics MarketsOverviewIntroductionDisclaimerCertificationResearch Scope and MethodologyStudy ObjectivesMarket Segmentation by Geographical RegionMarket Segmentation by DiseaseCompetitive LandscapeMajor Market ParticipantsGrowth Analysis by Neurological MarketPhase III ProductsPhase I and II Products APhase I and II Products BPhase I and II Products CAlzheimer's DiseasePrevalence by Geographical RegionCurrent Treatments and Market ParticipantsRevenue Growth AnalysisAlzheimer's Disease Market by Geographical RegionRevenue Growth by Geographical RegionMarket Share Analysis by CompanyMarket ChallengesMarket DriversMarket RestraintsClinical DevelopmentExecutive Quote (Alzheimer's Association)Pipeline AnalysisExecutive Quote (Axoynx)Product Analysis: PhenserineParkinson's DiseaseDisease OverviewMarket OverviewFirst-Line TherapySecond-Line TherapyPrevalence by Geographical RegionRevenue Growth AnalysisParkinson's Disease Market by Geographical RegionMarket Share Analysis by ProductMarket ChallengesMarket DriversMarket RestraintsClinical DevelopmentPipeline AnalysisExecutive Quote (Teva Neurosciences)Product Analysis: RasagalineMultiple SclerosisMarket OverviewPrevalence by Geographical RegionRevenue Growth AnalysisMultiple Sclerosis Market by Geographical RegionRevenue Growth by Geographical RegionMarket Share Analysis by ProductMarket ChallengesMarket DriversMarket RestraintsClinical DevelopmentExecutive Quote (National Multiple Sclerosis Society)Pipeline AnalysisExecutive Quote (The Immune Response Corporation)Executive Quote (Berlex)Executive Quote (Elan Pharmaceuticals)Product Analysis: AntegrenDecision Support DatabasesNumber of Alzheimer's PatientsPsychiatristsNeurologistsPhysiciansTotal Population 65 and AboveFrost & Sullivan AwardsIntroductionEntrepreneurial Company of the Year AwardIndustry Innovation and Advancement of the Year AwardTechnology Excellence AwardProduct Innovation AwardFrost & SullivanHealthcare TeamOur CapabilitiesKey AdvantagesOur Consulting ClientsGrowth ConsultingGrowth Consulting ProcessGrowth Consulting DeliverablesGrowth Partnership ServiceGrowth Partnership Service Platform




Related Research

Release Date : 10-Aug-17

Region : Global

Release Date : 09-Aug-17

Region : Global

Release Date : 07-Aug-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.